Rare Disease Treatments
Pharmaceutical and biotech companies developing orphan drugs and therapies for rare diseases affecting small patient populations
Symbols
LLYLilly(Eli) & CoMarket Cap: $907.9B
ABBVAbbvie IncMarket Cap: $397.5B
NOVNNovartis AGMarket Cap: $310.4B
NVONovo NordiskMarket Cap: $213.9B
AMGNAMGEN Inc.Market Cap: $202B
BRMBristol-Myers Squibb Co.Market Cap: $123.5B
BMYBristol-Myers Squibb Co.Market Cap: $123.5B
VRTXVertex Pharmaceuticals, Inc.Market Cap: $121.1B
REGNRegeneron Pharmaceuticals, Inc.Market Cap: $82.4B
SNYSanofiMarket Cap: $57B
ARGXArgen X SEMarket Cap: $51.3B
EDGGold Fields LtdMarket Cap: $48.4B
ALNYAlnylam Pharmaceuticals IncMarket Cap: $44.6B
INSMInsmed IncMarket Cap: $35.5B
TAKTakeda Pharmaceutical CoMarket Cap: $31.7B
ZLABZai Lab LimitedMarket Cap: $29.3B
BIIBBiogen IncMarket Cap: $28.2B
UTHRUnited Therapeutics CorpMarket Cap: $20.4B
INCYIncyte Corp.Market Cap: $20.2B
MRNAModerna IncMarket Cap: $19.7B